LUAD - Lung adenocarcinoma Back

External References: Wikipedia National Cancer Institute Google Scholar

iCoMut Beta for


Highly significantly mutated genes
TP53
207 patients (51%)
KRAS
108 patients (26%)
KEAP1
60 patients (14%)
EGFR
44 patients (10%)
STK11
42 patients (10%)
NF1
42 patients (10%)
SMARCA4
35 patients (8%)
BRAF
27 patients (6%)
CDKN2A
23 patients (5%)
MET
20 patients (4%)
RBM10
19 patients (4%)
PIK3CA
18 patients (4%)
RIT1
14 patients (3%)
U2AF1
12 patients (2%)
Significantly mutated genes
ATM
39 patients (9%)
ARID1A
28 patients (6%)
SLC4A5
19 patients (4%)
RB1
18 patients (4%)
ERBB2
15 patients (3%)
MAP2K1
11 patients (2%)
STX2
8 patients (1%)
NBPF1
6 patients (1%)
Genes near significance
MLL3
60 patients (14%)
FAT1
56 patients (13%)
APC
28 patients (6%)
ARID2
22 patients (5%)
SLC39A6
15 patients (3%)
ARHGAP35
14 patients (3%)
SMAD4
13 patients (3%)
CTNNB1
12 patients (2%)
CDK12
12 patients (2%)
MBD1
10 patients (2%)
FBXO16
8 patients (1%)
PBLD
6 patients (1%)
ZNF774
5 patients (1%)
NRAS
4 patients (0%)
CDKN1B
4 patients (0%)
Click on a gene to see details.

Notes


• Gene name color indicates: known cancer genes | highly compelling novel candidate cancer genes | other candidates

Data details


Mutation list for LUAD
Q-Q plots for LUAD